Four Models of Telephone Support for Stimulant Recovery
- Conditions
- Drug Addiction
- Interventions
- Behavioral: Continuing Care Telephone Support
- Registration Number
- NCT00744068
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
The overall objective of this research is to develop and refine empirically supported continuing care interventions that promote healthy behavior and sustained abstinence from illicit drug use.
- Detailed Description
For treatment interventions to provide the desired result of long term abstinence, it is important to develop strategies to enhance the effectiveness of continued care approaches. We plan to conduct a prospective, randomized comparison of four models of counselor-provided telephone support as strategies to promote patient aftercare attendance and sustained abstinence from stimulant use. To this end, we will develop and compare the efficacy of four low-cost telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program. Some 500 participants completing a 4-month Matrix Outpatient Model of stimulant abuse treatment will be randomly assigned to one of four counseling groups (n=100 per group): (1) unstructured/non-directive, (2) structured/non-directive, (3) unstructured/directive, or (4) structured/directive telephone counseling, or (5) a control group consisting of standard referral to Matrix aftercare, for a total sample size of 500. The two structured conditions will be based on the behavioral "prompts" identified by Farabee et al. (2002)\* as being associated with drug avoidance. In the non-directive conditions, subjects will be allowed to state their own goals and how they intend to achieve them. In the directive conditions, the counselor will provide specific recommendations to help the subject adopt as many of the drug-avoidance activities as possible. Outcomes will be tracked for 12 months following completion of primary treatment (a total of 16 months after treatment admission) and will include measurement of participation in drug-avoidance activities (including aftercare participation) as well as self-reported and objective measures of substance use and related behavior change.
\*Farabee, D., Rawson, R.A., \& McCann, M. (2002). Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. Journal of Substance Abuse Treatment, 23, 343-350.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 302
- Males or females, 18-65 years of age.
- Meet DSM-IV criteria (at the time of treatment admission) for cocaine or methamphetamine abuse/dependence.
- Have completed the primary phase of treatment at a Matrix outpatient clinic.
- Have telephone access throughout the study procedures.
- Be able to understand and complete rating scales and to follow instructions.
- Be willing to sign an informed consent form.
- Have participated in a treatment-related study conducted by the PI and colleagues during the previous 3 years and/or is currently enrolled in a treatment-related study.
- Have any medical, legal, housing or transportation problem which would preclude either safe or consistent participation.
- Have dropped out of the primary phase of treatment prior to completion.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Continuing Care Telephone Support Structured Directive Telephone Support Calls 2 Continuing Care Telephone Support Structured Non-Directive Telephone Continuing Care Support 3 Continuing Care Telephone Support Unstructured Directive Telephone Support 4 Continuing Care Telephone Support Unstructured Non-Directive Telephone Support
- Primary Outcome Measures
Name Time Method Urinalyses At 3 months and 12 months Breathalyzer tests At 3 months and 12 months Self-report of drug or alcohol use At 3 months and 12 months Amount of Treatment Activities At 3 months and 12 months Length of Treatment Episode At 3 months and 12 months
- Secondary Outcome Measures
Name Time Method Addiction Severity Index (ASI) At 3 months and 12 months HIV Risk-taking Behavior Scale At 3 months and 12 months Concurrent Psychosocial Treatments At 3 months and 12 months Drug Avoidance Activities (DAA) Survey At 3 months and 12 months
Trial Locations
- Locations (4)
UCLA Integrated Substance Abuse Programs
🇺🇸Los Angeles, California, United States
Matrix Institute on Addicitions
🇺🇸Woodland Hills, California, United States
Twin Town Treatment Center
🇺🇸West Hollywood, California, United States
Matrix Institute on Addictions
🇺🇸Rancho Cucamonga, California, United States